Somnomed Ltd
ASX:SOM
Somnomed Ltd
Revenue
Somnomed Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Somnomed Ltd
ASX:SOM
|
Revenue
AU$88.8m
|
CAGR 3-Years
17%
|
CAGR 5-Years
8%
|
CAGR 10-Years
15%
|
|
Neurotech International Ltd
ASX:NTI
|
Revenue
AU$1.3m
|
CAGR 3-Years
148%
|
CAGR 5-Years
83%
|
CAGR 10-Years
N/A
|
|
ImpediMed Ltd
ASX:IPD
|
Revenue
AU$10.5m
|
CAGR 3-Years
17%
|
CAGR 5-Years
24%
|
CAGR 10-Years
13%
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Revenue
AU$27.8m
|
CAGR 3-Years
24%
|
CAGR 5-Years
16%
|
CAGR 10-Years
9%
|
Cochlear Ltd
ASX:COH
|
Revenue
AU$2.1B
|
CAGR 3-Years
18%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Revenue
AU$7.1m
|
CAGR 3-Years
93%
|
CAGR 5-Years
70%
|
CAGR 10-Years
N/A
|
See Also
What is Somnomed Ltd's Revenue?
Revenue
88.8m
AUD
Based on the financial report for Dec 31, 2023, Somnomed Ltd's Revenue amounts to 88.8m AUD.
What is Somnomed Ltd's Revenue growth rate?
Revenue CAGR 10Y
15%
Over the last year, the Revenue growth was 13%. The average annual Revenue growth rates for Somnomed Ltd have been 17% over the past three years , 8% over the past five years , and 15% over the past ten years .